Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
Bladder cancer (BC) represents a clinical, social, and economic challenge due to tumor-intrinsic characteristics, limitations of diagnostic techniques and a lack of personalized treatments. In the last decade, the use of liquid biopsy has grown as a non-invasive approach to characterize tumors. More...
Main Authors: | Alba Loras, Cristina Segovia, José Luis Ruiz-Cerdá |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/11/2719 |
Similar Items
-
Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer
by: Alba Loras, et al.
Published: (2019-05-01) -
Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
by: Alba Loras, et al.
Published: (2019-06-01) -
Metabolomics approach for discovering disease biomarkers and understanding metabolic pathway
by: Jeeyoun Jung, et al.
Published: (2011-12-01) -
Functional Metabolomics Analysis Elucidating the Metabolic Biomarker and Key Pathway Change Associated With the Chronic Glomerulonephritis and Revealing Action Mechanism of Rhein
by: Wei Yu, et al.
Published: (2020-09-01) -
High-Throughput Metabolomics Method for Discovering Metabolic Biomarkers and Pathways to Reveal Effects and Molecular Mechanism of Ethanol Extract From Epimedium Against Osteoporosis
by: Jun-feng Zhao, et al.
Published: (2020-08-01)